patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
RIVAROXABAN
Marketedupdated 2mo agoby Reddy US Therapeutics Inc
Approvedannual revenue · 2024–2024peak $2.1B
community read0 votes
indications
investigational
Atrial Fibrillation
all catalysts(4)
approval · 4
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that